Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Martínez-González, L. Badimón (2007)
Mechanisms underlying the cardiovascular effects of COX-inhibition: benefits and risks.Current pharmaceutical design, 13 22
Gurkirpal Singh, O. Wu, P. Langhorne, R. Madhok (2006)
Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysisArthritis Research & Therapy, 8
P. Kearney, C. Baigent, J. Godwin, H. Halls, J. Emberson, C. Patrono (2006)
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsBMJ : British Medical Journal, 332
E. Antman, J. Bennett, A. Daugherty, C. Furberg, H. Roberts, K. Taubert (2007)
Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association.Circulation, 115 12
R. Bresalier, R. Sandler, H. Quan, J. Bolognese, B. Oxenius, K. Horgan, C. Lines, R. Riddell, D. Morton, Á. Lanas, M. Konstam, J. Baron (2005)
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.The New England journal of medicine, 352 11
D. Graham, D. Campen, R. Hui, Michele Spence, C. Cheetham, Gerald. Levy, S. Shoor, W. Ray (2005)
Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control studyThe Lancet, 365
E. Garbe, M. Suling, S. Kloss, C. Lindemann, U. Schmid (2011)
Linkage of mother–baby pairs in the German Pharmacoepidemiological Research DatabasePharmacoepidemiology and Drug Safety, 20
L. Lévesque, J. Brophy, Bin Zhang (2005)
The Risk for Myocardial Infarction With Cyclooxygenase-2 Inhibitors: A Population Study of Elderly AdultsObstetrics & Gynecology, 106
(2008)
Philadelphia: Wolters Kluwer Health
P. McGettigan, D. Henry (2011)
Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational StudiesPLoS Medicine, 8
Roger Jones (2001)
Nonsteroidal anti-inflammatory drug prescribing: past, present, and future.The American journal of medicine, 110 1A
B. Thiers (2007)
Cardiovascular Risk and Inhibition of Cyclooxygenase: A Systematic Review of the Observational Studies to Selective and Nonselective Inhibitors of Cyclooxygenase 2Yearbook of Dermatology and Dermatologic Surgery, 2007
S. Trelle, S. Reichenbach, Simon Wandel, Pius Hildebrand, B. Tschannen, Peter Villiger, Matthias Egger, Peter Jüni (2011)
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysisThe BMJ, 342
F. Andersohn, S. Suissa, E. Garbe (2006)
Use of First- and Second-Generation Cyclooxygenase-2–Selective Nonsteroidal Antiinflammatory Drugs and Risk of Acute Myocardial InfarctionCirculation, 113
T. Grosser, Susanne Fries, G. FitzGerald (2005)
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.The Journal of clinical investigation, 116 1
M. Graffar (1971)
[Modern epidemiology].Bruxelles medical, 51 10
C. Varas‐Lorenzo, J. Castellsagué, M. Stang, S. Perez-Gutthann, J. Aguado, L. Rodríguez (2009)
The use of selective cyclooxygenase‐2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, CanadaPharmacoepidemiology and Drug Safety, 18
S. Schneeweiss, J. Avorn (2005)
A review of uses of health care utilization databases for epidemiologic research on therapeutics.Journal of clinical epidemiology, 58 4
W. Ray (2003)
Evaluating medication effects outside of clinical trials: new-user designs.American journal of epidemiology, 158 9
N. Abraham, H. El‐Serag, C. Hartman, Paul Richardson, A. Deswal (2007)
Cyclooxygenase‐2 selectivity of non‐steroidal anti‐inflammatory drugs and the risk of myocardial infarction and cerebrovascular accidentAlimentary Pharmacology & Therapeutics, 25
W. Ray, C. Varas‐Lorenzo, C. Chung, J. Castellsagué, K. Murray, C. Stein, J. Daugherty, P. Arbogast, L. García-Rodríguez (2009)
Cardiovascular Risks of Nonsteroidal Antiinflammatory Drugs in Patients After Hospitalization for Serious Coronary Heart DiseaseCirculation: Cardiovascular Quality and Outcomes, 2
L. Rodríguez, A. Gonzáléz-Pérez (2005)
Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general populationBMC Medicine, 3
S. Johnsen, H. Larsson, R. Tarone (2005)
Risks of Hospitalization for Myocardial Infarction Among Users of Rofecoxib, Celecoxib, and Other NSAIDsAcc Current Journal Review, 14
P. McGettigan, D. Henry (2006)
Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.JAMA, 296 13
I. Pigeot, W. Ahrens (2008)
Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitationsPharmacoepidemiology and Drug Safety, 17
S. Johnsen, H. Larsson, R. Tarone, J. Mclaughlin, B. Nørgård, S. Friis, H. Sørensen (2005)
Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.Archives of internal medicine, 165 9
M. Linden, S. Bij, P. Welsing, E. Kuipers, R. Herings (2008)
The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugsAnnals of the Rheumatic Diseases, 68
D. Solomon, R. Glynn, R. Levin, J. Avorn (2002)
Nonsteroidal anti-inflammatory drug use and acute myocardial infarction.Archives of internal medicine, 162 10
L. Lévesque, J. Brophy, Bin Zhang (2006)
Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitorsCanadian Medical Association Journal, 174
L. Rodríguez, S. Tacconelli, P. Patrignani (2008)
Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population.Journal of the American College of Cardiology, 52 20
C. Varas‐Lorenzo, N. Riera‐Guardia, B. Calingaert, J. Castellsagué, F. Salvo, F. Nicotra, M. Sturkenboom, S. Perez-Gutthann (2013)
Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studiesPharmacoepidemiology and Drug Safety, 22
D. Solomon, J. Avorn, T. Stürmer, R. Glynn, H. Mogun, S. Schneeweiss (2006)
Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.Arthritis and rheumatism, 54 5
J. Brophy, L. Lévesque, Bin Zhang (2005)
The coronary risk of cyclo-oxygenase-2 inhibitors in patients with a previous myocardial infarctionHeart, 93
A. Helin‐Salmivaara, A. Virtanen, R. Vesalainen, J. Grönroos, T. Klaukka, J. Idänpään-Heikkilä, R. Huupponen (2006)
NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland.European heart journal, 27 14
E. Fosbøl, F. Folke, S. Jacobsen, J. Rasmussen, R. Sørensen, T. Schramm, S. Andersen, S. Rasmussen, H. Poulsen, L. Køber, C. Torp-Pedersen, G. Gislason (2010)
Cause-Specific Cardiovascular Risk Associated With Nonsteroidal Antiinflammatory Drugs Among Healthy IndividualsCirculation: Cardiovascular Quality and Outcomes, 3
S. Hernández-Díaz, C. Varas‐Lorenzo, L. Rodríguez (2006)
Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction.Basic & clinical pharmacology & toxicology, 98 3
J. Hippisley-Cox, C. Coupland (2005)
Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysisBMJ : British Medical Journal, 330
Anne-Marie Olsen, E. Fosbøl, J. Lindhardsen, F. Folke, M. Charlot, C. Selmer, M. Lamberts, Jonas Olesen, L. Køber, Peter Hansen, C. Torp-Pedersen, G. Gislason (2011)
Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction: A Nationwide Cohort StudyCirculation, 123
L. Rodríguez, C. Varas‐Lorenzo, A. Maguire, A. Gonzáléz-Pérez (2004)
Nonsteroidal Antiinflammatory Drugs and the Risk of Myocardial Infarction in the General PopulationCirculation: Journal of the American Heart Association, 109
S. Rich (2001)
The coxibs, selective inhibitors of cyclooxygenase-2.The New England journal of medicine, 345 23
K. Rothman, S. Greenland, T. Lash (1986)
Modern Epidemiology 3rd edition
GA FitzGerald, C Patrono (2001)
The coxibs, selective inhibitors of cyclooxygenase-2N Engl J Med, 345
Drugs - Real World Outcomes (2017) 4:127–137 DOI 10.1007/s40801-017-0113-x ORIGINAL RESEARCH ARTICLE Non-Steroidal Anti-Inflammatory Drug Use and the Risk of Acute Myocardial Infarction in the General German Population: A Nested Case–Control Study 1,2 1 1 • • Kathrin Tho¨ne Bianca Kollhorst Tania Schink Published online: 4 July 2017 The Author(s) 2017. This article is an open access publication Abstract sampling. Multivariable conditional logistic regression was Introduction Use of non-steroidal anti-inflammatory drugs applied to estimate odds ratios (ORs) and 95% confidence (NSAIDs) has been associated with an increased relative intervals (CIs). Duration of NSAID use was calculated by risk of acute myocardial infarction (AMI), but the label the cumulative amount of dispensed defined daily doses warnings refer particularly to patients with cardiovascular (DDDs), and stratified analyses were conducted for risk factors. The magnitude of relative AMI risk for potential effect modifiers. patients with and without cardiovascular risk factors varies Results Overall, 17,236 AMI cases were matched to between studies depending on the drugs and doses studied. 1,714,006 controls. Elevated relative AMI risks were seen Objectives The aim of our study was to estimate popula- for current users of fixed combinations of diclofenac with tion-based relative AMI risks for individual and
Drugs - Real World Outcomes – Springer Journals
Published: Jul 4, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.